Growth factor IGF-Il
US5482926A · kind A · utility
3Cited by
0References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 17, 1994 |
| Grant date | Jan 9, 1996 |
| Priority date | — |
| Expiry date | Feb 17, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of iGF-II or effective analogues thereof for the manufacture of a medicament for prevention or treatment of nutritional or gastrointestinal disorders and for promoting human or animal neonatal growth. It also relates to composition comprising exogenous human or animal IGF-II or effective analogues thereof in a therapeutically effective amount together with a pharmaceutically acceptable carrier or diluent or foodstuff, preferably in admixture with artificial or natural milk or colostrum. The invention may be applied both in man and in animals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.